Abstract
Microsomal prostaglandin E2 synthase (mPGES-1) has been identified recently as a novel target for treating pain and inflammation. The aim of this study is to understand the binding affinities of reported inhibitors for mPGES-1 and further to design potential new mPGES-1 inhibitors. 3D-QSAR-CoMFA (comparative molecular field analysis) and CoMSIA (comparative molecular similarity indices analysis) - techniques were employed on a series of indole derivatives that act as selective mPGES-1 inhibitors. The lowest energy conformer of the most active compound obtained from systematic conformational search was used as a template for the alignment of 32 compounds. The models obtained were used to predict the activities of the test set of eight compounds, and the predicted values were in good agreement with the experimental results. The 3D-QSAR models derived from the training set of 24 compounds were all statistically significant (CoMFA; q 2 = 0.89, r 2 = 0.95, \( r^{{\text{2}}}_{{{\text{bs}}}} = 0.98 \), \( r^{{\text{2}}}_{{{\text{pred}}}} = 0.83 \) and CoMSIA; q 2 = 0.84, r 2 = 0.93, \( r^{{\text{2}}}_{{{\text{bs}}}} = 0.93 \), \( r^{{\text{2}}}_{{{\text{pred}}}} = 0.94 \)). Contour plots generated for the CoMFA and CoMSIA models reveal useful clues for improving the activity of mPGES-1 inhibitors. In particular, substitutions of an electronegative fluorine atom or a bulky hydrophilic phenoxy group at the meta or para positions of the biphenyl rings might improve inhibitory activity. A plausible binding mode between the ligands and mPGES-1 is also proposed.
Similar content being viewed by others
References
Schmidt RF, Schaible HG, Messlinger K, Heppelmann B, Hanesch U, Pawlak M (1994) Progress in pain and management. In: Gebhart GF, Hammond DL, Jensen TS (eds) Proc 7th World Congress on Pain (2nd edn.) Seattle, IASP, Chap 16
Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H, Xiao SY, Winston JH, Pasricha PJ (2001) J Neurosci 21(22):9036–9042
Yang HYT, Iadarola MJ (2006) Peptides 27(5):943–952
Wan WZ, Zhang N (2006) Zhongguo Shengwu Huaxue Yu Fenzi Shengwu Xuebao 22(2):101–105
Shukla AK, Haase W, Reinhart C, Michel H (2006) Biol Chem 387(5):569–576
Qin X, Zhang H (2005) Zhongguo Linchuang Kangfu 9(17):145–147
Gilmour RS, Mitchell MD (2001) Exp Biol Med 226:1–4
Kudo I, Murakami M (2005) J Biochem Mol Biol 38(6):633–638
Murakami K, Kudo M (2004) Prog Lipid Res 43:3–35
Sampey AV, Monrad S, Crofford LJ (2005) Arthritis Res Therapy 7(3):114–117
Trebino CE, Stock JL, Gibbons CP, Naiman BN, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML, Carter D, Thomas NA, Durtschi BA, McNeish JD, Hambor JE, Jakobsson P, Carty TJ, Perez JR, Audoly LP (2003) Proc Natl Acad Sci USA 100:9044–9049
Duffy D, Seachord C, Dozier B (2005) Hum Reprod 20(6):1485–1492
Uematsu S, Matsumoto M, Takeda K, Akira S (2002) J Immunol 168:5811–5816
Thoren S, Jakobsson PJ (2000) Eur J Biochem 267:6428–6434
Quraishi O, Mancini J, Riendeau D (2002) Biochem Pharmacol 63:1183–1189
Riendeau D, Aspiotis R, Ethier D, Gareau Y, Grimm E, Guay J, Guiral S, Juteau H, Mancini J, Methot N, Rubin J, Friesen R (2005) Bioorg Med Chem Lett 15:3352–3355
Cramer III RD, Patterson DE, Bunce JD (1988) J Am Chem Soc 110:5959–5967
Klebe G, Abraham U, Mietzner T (1994) J of Med Chem 37:4130–4146
SYBYL 7.2 (2006) Tripos Inc., St. Louis, MO 63144
Clark M, Cramer III R, Van Opdenbosch N (1989) J Comput Chem 10:982–1012
Kim K, Greco G, Novellino E (1998) Perspect Drug Discov Des 12–14:257–315
Wold S, Albano C, Dunn W, Edlund U, Esbensen K, Geladi P, Hellberg S, Johansson E, Lindberg W, Sjosstrom M (1987) Chemometrics: mathematics and statistics in chemistry. In: Kowalski B (ed) Reidel, Dordrecht, The Netherlands pp 17–95
Bush BL, Nachbar RB (1993) J Comput Aided Mol Des 7:587–619
Stahle L, Wold S (1988) Prog Med Chem 25:292–338
Cramer III RD, Bunce JD, Patterson DE, Frank IE (1988) Quant Struc-Act Relat 7:18–25
Clark RD, Sprous DG, Leonard JM (2001) Validating models based on large data sets. In: Höltje HD, Sippl W (eds) 13th european symposium on quantitative structure-activity relationships: rational approaches to drug design. Prous Science, Barcelona-Philadelphia pp 475–485
Mancini JA, Blood K, Guay J, Gordon R, Claveau D, Chan C, Riendeau D (2001) J Biol Chem 276(6):4469–4475
Jakobsson P, Morgenstern R, Mancini J, Hutchinson AF, Persson B (1999) Prot Sci 8:689–692
Acknowledgement
The study was supported by the Korea Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
San Juan, A.A., Cho, S.J. 3D-QSAR study of microsomal prostaglandin E2 synthase(mPGES-1) inhibitors. J Mol Model 13, 601–610 (2007). https://doi.org/10.1007/s00894-007-0172-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-007-0172-0